Sarcopenia in Cirrhosis: Fallout on Liver Transplantation

被引:43
|
作者
Kumar, Vaibhaw [1 ]
Benjamin, Jaya [2 ]
Shasthry, Varsha [2 ]
Bharathy, Kishore G. Subramanya [1 ]
Sinha, Piyush K. [1 ]
Kumar, Guresh [3 ]
Pamecha, Viniyendra [1 ]
机构
[1] Inst Liver & Biliary Sci, Dept Hepato Pancreato Biliary & Liver Transplant, New Delhi, India
[2] Inst Liver & Biliary Sci, Dept Clin Nutr, New Delhi, India
[3] Inst Liver & Biliary Sci, Dept Clin Res, New Delhi, India
关键词
nutritional status; asian indian; chronic liver disease; skeletal muscle area; liver transplant outcome; SKELETAL-MUSCLE MASS; WHOLE-BODY; IMPACT; OUTCOMES; COMPLICATIONS; SURVIVAL; COHORT; INDEX;
D O I
10.1016/j.jceh.2019.12.003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Liver transplantation (LT) is a game changer in cirrhosis. Poor muscle mass defined as sarcopenia may potentially upset the LT scoreboard. Aim: To assess the prevalence and impact of sarcopenia on the intraoperative and early postoperative outcomes in Indian patients undergoing LT. Methods: Pre LT, single-slice routine computed tomography images at L3 vertebra of 115 LT recipients were analyzed, to obtain cross-sectional area of six skeletal muscles normalized for height in m(2) - skeletal muscle index (SMI; cm(2)/m(2)). SMI < 52.4 in males and <38.5 in females was called sarcopenia. The intraoperative, postoperative outcome parameters and 90-day mortality were compared between sarcopenics and nonsarcopenics. Results: Sarcopenia was found in 47.8% of patients [M (90.4%); age, 46.3 +/- 10; BMI, 24.5 +/- 4.3 kg/m2; child A:B:C = 1%:22%:77%; MELD, 20.6 +/- 6.3; etiology alcohol: nonalchohol = 53%:47%; Charlson Comorbidity Index (CCI) > 3:<= 3 = 56.5%:43.5%]. Sarcopenics vs. Nonsarcopenics; early postoperative complications: [sepsis, 49(89%) vs. 33(55%), P = 0.001; neurologic complications, 16(29.6%) vs. 5(8.8%), P = 0.040; Clavien-Dindo Classification 3-24 (43.6%):15 (25.4%),P = 0.041; ancillary parameters (days), duration of ventilation [median (range)] 1.5(1-3) vs. 1 (1-2), P = 0.021; intensive care unit (ICU) stay 12 (8-16) vs. 10 (8-12), P = 0.024; time to ambulation 9 (7-11) vs. 6 (5-7), P = 0.001; drain removal 18.7 +/- 7.3 vs. 14.4 +/- 6.2, P = 0.001; need for tracheostomy 5 (9%) vs. 0 (%), P = 0.017; preoperative prevalence of acute kidney injury, comorbidities and requirement for dialysis, intraoperative blood loss & inotropic support were significantly higher in sarcopenics. Ninety-day mortality was comparable between sarcopenics 5 (9.09%) and nonsarcopenics 4 (6.6%) P = 0.63. SMI (OR: 0.83; 95% CI: 0.71-0.97, P = 0.016; Acute on chronic liver failure (ACLF) presentation 12.5 (1.65-95.2), P = 0.015 and intraoperative blood loss 3.74 (0.96-14.6), P = 0.046 were predictors of 90-day mortality. Conclusion: Almost 50% of LT recipients had sarcopenia, who had a higher incidence of postoperative sepsis, neurological complications, longer ICU stay and ventilatory support. Low SMI, ACLF presentation, and intraoperative blood loss were the independent predictors of early mortality.
引用
收藏
页码:467 / 476
页数:10
相关论文
共 50 条
  • [1] Sarcopenia of Cirrhosis Does Not Reverse after Liver Transplantation
    Yadav, A.
    Carpenter
    Chang
    Silva
    Aqel
    Byrne
    Douglas
    Vargas
    Carey
    AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 220 - 220
  • [2] Sarcopenia in cirrhosis before living donor liver transplantation
    Acar, S.
    Gencdal, G.
    Alkara, U.
    Eren, E.
    Topac, M.
    Tellioglu, G.
    Dinckan, A.
    Akyildiz, M.
    TRANSPLANTATION, 2018, 102 : 131 - 131
  • [3] Post-liver transplantation sarcopenia in cirrhosis: A prospective evaluation
    Tsien, Cynthia
    Garber, Ari
    Narayanan, Arvind
    Shah, Shetal N.
    Barnes, David
    Eghtesad, Bijan
    Fung, John
    McCullough, Arthur J.
    Dasarathy, Srinivasan
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 (06) : 1250 - 1257
  • [4] EXPLORATION OF SARCOPENIA INDEX IN PATIENTS WITH CIRRHOSIS UNDERGOING LIVER TRANSPLANTATION
    Choi, Chansong
    Johnson, Bradley K.
    Takahashi, Naoki
    Barreto, Erin F.
    Kamath, Patrick S.
    Shah, Vijay
    Kashani, Kianoush B.
    Simonetto, Douglas A.
    HEPATOLOGY, 2022, 76 : S1147 - S1147
  • [5] A New Definition of Sarcopenia in Patients With Cirrhosis Undergoing Liver Transplantation
    Golse, Nicolas
    Bucur, Petru Octav
    Ciacio, Oriana
    Pittau, Gabriella
    Cunha, Antonio Sa
    Adam, Rene
    Castaing, Denis
    Antonini, Teresa
    Coilly, Audrey
    Samuel, Didier
    Cherqui, Daniel
    Vibert, Eric
    LIVER TRANSPLANTATION, 2017, 23 (02) : 143 - 154
  • [6] Post Liver Transplantation Sarcopenia in Cirrhosis: Mechanisms and Prospective Evaluation
    Tsien, Cynthia
    Garber, Ari
    Narayanan, Arvind
    Shah, Shetal
    Barnes, David S.
    Eghtesad, Bijan
    Fung, John J.
    McCullough, Arthur J.
    Dasarathy, Srinivasan
    GASTROENTEROLOGY, 2013, 144 (05) : S998 - S998
  • [7] Impact of sarcopenia on the survival of patients undergoing liver transplantation for decompensated liver cirrhosis
    Zhou, Da
    Zhang, Donghua
    Zeng, Chenghao
    Zhang, Li
    Gao, Xuejin
    Wang, Xinying
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2023, 14 (06) : 2602 - 2612
  • [8] Cirrhosis-related sarcopenia may not resolve after liver transplantation
    Brown, Sara
    Richardson, Brooks
    Bouquet, Erin
    Reid, Elise
    Mercer, Evan
    Goncalves, Michael
    Spann, Ashley
    Annis, Jeffrey
    Brittain, Evan
    Dreher, Anthony
    Alexopoulos, Sophoclis
    Slaughter, James C.
    Silver, Heidi J.
    Izzy, Manhal
    JHEP REPORTS, 2023, 5 (11)
  • [9] Sarcopenia and Frailty in Liver Cirrhosis
    Nishikawa, Hiroki
    Fukunishi, Shinya
    Asai, Akira
    Nishiguchi, Shuhei
    Higuchi, Kazuhide
    LIFE-BASEL, 2021, 11 (05):
  • [10] Sarcopenia in Liver Transplantation
    John Montgomery
    Michael Englesbe
    Current Transplantation Reports, 2019, 6 : 7 - 15